Elevated levels of pro-inflammatory cytokines, particularly tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and interleukin-17 (IL-17), are fundamental to both RA and leukemia progression [24]. Here, IL17A is linked to leukemia.